TLDR yields 0.54% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, TLDR + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TLDR + JNJ for your $10,000?
TLDR uses a laddered maturity approach to a portfolio of US T-Bills, targeting a dollar-weighted average maturity of approximately 60 days. Investments primarily consist of T-Bills with remaining maturities of six months or less, and may also hold cash, cash equivalents, or treasury-backed money market instruments. The sub-adviser manages the ladder and reinvestment timing to optimize yield along the front end of the US Treasury curve, and may tactically adjust the portfolios average maturity. It may be extended when market conditions favor slightly longer-dates bills, or reduced to 30 days or less to preserve liquidity or limit interest-rate risk. The strategy spreads investments across multiple near-term maturities to help manage interest-rate exposure and generate regular cash flows. As positions mature, the fund continuously rolls the portfolio into newly issued T-Bills at market rates, which may result in high portfolio turnover.
Full TLDR Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.